Internally, we have developed a unique, non-systemic drug concept which aims for innovative medicines acting within the intestinal lumen on the apical side of the gut.
The concept utilizes the "Tango" approach ("it takes two to tango"), either aiming at modulation of a network of disease-relevant targets, addressing the multifaceted nature of many diseases, or to anchor the molecule in the gut membrane.
All diseases start in the gut
(Hippocrates)
The concept operates in known chemical spaces, thus facilitating lead generation and allowing for faster candidate drug (CD) delivery. Fewer variables need to be optimized. Furthermore, it minimizes the risk for toxicity and side effects allowing for durable action via persistent target modulation
Contact us to learn more about the concept